To avoid the usage of transgenic mice that artificially harbor mono-specific B cells expressing a defined BCR that recognizes either a transgene product or endogenous structure, we selected insulin-related autoantigens as a physiologically relevant system for autoimmune diseases (Amendt and Jumaa 2021, in press). This evidence concerns the gene INS and autoimmune disease.